The role of backbone conformational heat capacity in protein stability: temperature dependent dynamics of the B1 domain of Streptococcal protein G.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMC 2144655)

Published in Protein Sci on June 01, 2000

Authors

M J Seewald1, K Pichumani, C Stowell, B V Tibbals, L Regan, M J Stone

Author Affiliations

1: Department of Chemistry, Indiana University, Bloomington 47405-0001, USA.

Articles citing this

FAST-Modelfree: a program for rapid automated analysis of solution NMR spin-relaxation data. J Biomol NMR (2003) 2.28

The response of internal dynamics to hydrophobic core mutations in the SH3 domain from the Fyn tyrosine kinase. Protein Sci (2004) 1.02

Water proton spin saturation affects measured protein backbone 15N spin relaxation rates. J Magn Reson (2011) 0.96

Temperature-dependent spectral density analysis applied to monitoring backbone dynamics of major urinary protein-I complexed with the pheromone 2- sec-butyl-4,5-dihydrothiazole. J Biomol NMR (2004) 0.95

Analysis of side chain mobility among protein G B1 domain mutants with widely varying stabilities. Protein Sci (2004) 0.85

Structural basis for the association of the redox-sensitive target of rapamycin FATC domain with membrane-mimetic micelles. J Biol Chem (2009) 0.84

15N relaxation study of the cold shock protein CspB at various solvent viscosities. J Biomol NMR (2003) 0.83

Structural and motional contributions of the Bacillus subtilis ClpC N-domain to adaptor protein interactions. J Mol Biol (2009) 0.82

Comparison of (13)C(alpha)H and (15)NH backbone dynamics in protein GB1. Protein Sci (2003) 0.82

Thermal coefficients of the methyl groups within ubiquitin. Protein Sci (2012) 0.82

Temperature dependence of fast carbonyl backbone dynamics in chicken villin headpiece subdomain. J Biomol NMR (2011) 0.81

15N nuclear magnetic resonance relaxation studies on rat beta-parvalbumin and the pentacarboxylate variants, S55D and G98D. Protein Sci (2002) 0.81

Structural Rigidity and Protein Thermostability in Variants of Lipase A from Bacillus subtilis. PLoS One (2015) 0.80

Conformational studies of the alpha-helical 28-43 fragment of the B3 domain of the immunoglobulin binding protein G from Streptococcus. Biopolymers (2008) 0.78

Heat Capacity Changes for Transition-State Analogue Binding and Catalysis with Human 5'-Methylthioadenosine Phosphorylase. ACS Chem Biol (2016) 0.77

(13)C-(1)H NMR relaxation and fluorescence anisotropy decay study of tyrosine dynamics in motilin. Biophys J (2002) 0.77

Comparison of the backbone dynamics of a natural and a consensus designed 3-TPR domain. J Biomol NMR (2008) 0.76

Applications of NMR spin relaxation methods for measuring biological motions. Methods Enzymol (2004) 0.76

NMR- and circular dichroism-monitored lipid binding studies suggest a general role for the FATC domain as membrane anchor of phosphatidylinositol 3-kinase-related kinases (PIKK). J Biol Chem (2013) 0.76

Temperature dependence of molecular interactions involved in defining stability of glutamine binding protein and its complex with L-glutamine. Biochemistry (2012) 0.75

Chimeric Avidin--NMR structure and dynamics of a 56 kDa homotetrameric thermostable protein. PLoS One (2014) 0.75

Site-Specific Internal Motions in GB1 Protein Microcrystals Revealed by 3D (2)H-(13)C-(13)C Solid-State NMR Spectroscopy. J Am Chem Soc (2016) 0.75

Articles cited by this

1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR (1995) 15.76

Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry (1994) 13.94

Backbone dynamics of proteins as studied by 15N inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease. Biochemistry (1989) 10.50

Backbone 1H and 15N resonance assignments of the N-terminal SH3 domain of drk in folded and unfolded states using enhanced-sensitivity pulsed field gradient NMR techniques. J Biomol NMR (1994) 6.06

A novel, highly stable fold of the immunoglobulin binding domain of streptococcal protein G. Science (1991) 6.00

Backbone dynamics of Escherichia coli ribonuclease HI: correlations with structure and function in an active enzyme. J Mol Biol (1995) 5.58

Backbone dynamics of calmodulin studied by 15N relaxation using inverse detected two-dimensional NMR spectroscopy: the central helix is flexible. Biochemistry (1992) 4.25

Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol (1984) 3.56

Effect of librational motion on fluorescence depolarization and nuclear magnetic resonance relaxation in macromolecules and membranes. Biophys J (1980) 3.45

Measurement of the beta-sheet-forming propensities of amino acids. Nature (1994) 3.36

A thermodynamic scale for the beta-sheet forming tendencies of the amino acids. Biochemistry (1994) 2.98

Increased protein backbone conformational entropy upon hydrophobic ligand binding. Nat Struct Biol (1999) 2.85

Contributions to conformational entropy arising from bond vector fluctuations measured from NMR-derived order parameters: application to protein folding. J Mol Biol (1996) 2.85

Spectral density function mapping using 15N relaxation data exclusively. J Biomol NMR (1995) 2.77

Two crystal structures of the B1 immunoglobulin-binding domain of streptococcal protein G and comparison with NMR. Biochemistry (1994) 2.67

Thermodynamic analysis of the folding of the streptococcal protein G IgG-binding domains B1 and B2: why small proteins tend to have high denaturation temperatures. Biochemistry (1992) 2.56

Context is a major determinant of beta-sheet propensity. Nature (1994) 2.53

Context-dependent secondary structure formation of a designed protein sequence. Nature (1996) 2.42

The heat capacity of proteins. Proteins (1995) 2.37

Analysis of the backbone dynamics of interleukin-1 beta using two-dimensional inverse detected heteronuclear 15N-1H NMR spectroscopy. Biochemistry (1990) 2.36

Protein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies. J Immunol (1985) 2.33

Calculations on folding of segment B1 of streptococcal protein G. J Mol Biol (1998) 2.19

Folding of protein G B1 domain studied by the conformational characterization of fragments comprising its secondary structure elements. Eur J Biochem (1995) 2.15

Insights into the local residual entropy of proteins provided by NMR relaxation. Protein Sci (1996) 2.03

Probing the role of packing specificity in protein design. Proc Natl Acad Sci U S A (1997) 1.97

Kinetic analysis of folding and unfolding the 56 amino acid IgG-binding domain of streptococcal protein G. Biochemistry (1992) 1.93

Determinants of protein hydrogen exchange studied in equine cytochrome c. Protein Sci (1998) 1.92

Guidelines for protein design: the energetics of beta sheet side chain interactions. Science (1995) 1.88

Temperature dependence of intramolecular dynamics of the basic leucine zipper of GCN4: implications for the entropy of association with DNA. J Mol Biol (1999) 1.71

Fast folding of a prototypic polypeptide: the immunoglobulin binding domain of streptococcal protein G. Protein Sci (1994) 1.69

Protein dynamics studied by rotating frame 15N spin relaxation times. J Biomol NMR (1993) 1.62

A thermodynamic comparison of mesophilic and thermophilic ribonucleases H. Biochemistry (1999) 1.58

The denaturation and degradation of stable enzymes at high temperatures. Biochem J (1996) 1.57

Dynamics of ribonuclease H: temperature dependence of motions on multiple time scales. Biochemistry (1996) 1.52

Hydrogen-deuterium exchange in the free and immunoglobulin G-bound protein G B-domain. Biochemistry (1994) 1.40

Investigation of the backbone dynamics of the IgG-binding domain of streptococcal protein G by heteronuclear two-dimensional 1H-15N nuclear magnetic resonance spectroscopy. Protein Sci (1994) 1.38

Characterization of the backbone dynamics of folded and denatured states of an SH3 domain. Biochemistry (1997) 1.31

Frequency spectrum of NH bonds in eglin c from spectral density mapping at multiple fields. Biochemistry (1995) 1.29

An early intermediate in the folding reaction of the B1 domain of protein G contains a native-like core. Biochemistry (1997) 1.28

1.67-A X-ray structure of the B2 immunoglobulin-binding domain of streptococcal protein G and comparison to the NMR structure of the B1 domain. Biochemistry (1992) 1.27

Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization. Biochem J (1995) 1.27

Backbone dynamics of the Bacillus subtilis glucose permease IIA domain determined from 15N NMR relaxation measurements. Biochemistry (1992) 1.26

Effects of ion binding on the backbone dynamics of calbindin D9k determined by 15N NMR relaxation. Biochemistry (1993) 1.25

Backbone dynamics and energetics of a calmodulin domain mutant exchanging between closed and open conformations. J Mol Biol (1999) 1.23

Pervasive conformational fluctuations on microsecond time scales in a fibronectin type III domain. Nat Struct Biol (1998) 1.23

Structural and dynamic characterization of the urea denatured state of the immunoglobulin binding domain of streptococcal protein G by multidimensional heteronuclear NMR spectroscopy. Protein Sci (1995) 1.22

Correlation between the amide proton exchange rates and the denaturation temperatures in globular proteins related to the basic pancreatic trypsin inhibitor. J Mol Biol (1979) 1.16

Assessment of stability differences in the protein G B1 and B2 domains from hydrogen-deuterium exchange: comparison with calorimetric data. Biochemistry (1995) 1.16

Thermophilic proteins: stability and function in aqueous and organic solvents. Comp Biochem Physiol A Physiol (1997) 1.13

Contributions to protein entropy and heat capacity from bond vector motions measured by NMR spin relaxation. J Mol Biol (1997) 1.12

Comparison of backbone and tryptophan side-chain dynamics of reduced and oxidized Escherichia coli thioredoxin using 15N NMR relaxation measurements. Biochemistry (1993) 1.09

15N NMR relaxation studies of free and inhibitor-bound 4-oxalocrotonate tautomerase: backbone dynamics and entropy changes of an enzyme upon inhibitor binding. Biochemistry (1996) 1.09

Propagation of experimental uncertainties using the Lipari-Szabo model-free analysis of protein dynamics. J Biomol NMR (1998) 1.03

Glyceraldehyde-3-phosphate dehydrogenase from Thermotoga maritima: strategies of protein stabilization. FEMS Microbiol Rev (1996) 1.02

Backbone dynamics of the C-terminal domain of Escherichia coli topoisomerase I in the absence and presence of single-stranded DNA. Biochemistry (1996) 1.00

Thermodynamic genetics of the folding of the B1 immunoglobulin-binding domain from streptococcal protein G. Proteins (1995) 0.96

Complement assembly of two fragments of the streptococcal protein G B1 domain in aqueous solution. FEBS Lett (1995) 0.92

Core mutants of the immunoglobulin binding domain of streptococcal protein G: stability and structural integrity. FEBS Lett (1996) 0.91

Probing residual structure and backbone dynamics on the milli- to picosecond timescale in a urea-denatured fibronectin type III domain. J Mol Biol (1999) 0.89

Backbone dynamics of a winged helix protein and its DNA complex at different temperatures: changes of internal motions in genesis upon binding to DNA. J Mol Biol (1999) 0.88

Insights into the molecular basis of thermal stability from the structure determination of Pyrococcus furiosus glutamate dehydrogenase. FEMS Microbiol Rev (1996) 0.84

Backbone dynamics of apocytochrome b5 in its native, partially folded state. Biochemistry (1999) 0.80

Articles by these authors

(truncated to the top 100)

Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord (2001) 5.97

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) BMJ (1997) 4.54

A thermodynamic scale for the beta-sheet forming tendencies of the amino acids. Biochemistry (1994) 2.98

The modern preventative treatment of recurrent miscarriage. Br J Obstet Gynaecol (1996) 2.90

Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids. BJOG (2008) 2.89

Increased protein backbone conformational entropy upon hydrophobic ligand binding. Nat Struct Biol (1999) 2.85

Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones. EMBO J (1999) 2.71

An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod (1994) 2.38

Thrombophilia in pregnancy: a systematic review. Br J Haematol (2006) 2.33

Protein alchemy: changing beta-sheet into alpha-helix. Nat Struct Biol (1997) 2.23

Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing. Gut (2000) 2.19

Campylobacter laridis causing bacteremia in an immunosuppressed patient. Ann Intern Med (1984) 2.14

Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod (2008) 2.06

The risks associated with pregnancy in women aged 35 years or older. Hum Reprod (2000) 2.06

Modular arrangement of functional domains along the sequence of an aminoacyl tRNA synthetase. Nature (1984) 2.04

Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet (2002) 1.95

Guidelines for protein design: the energetics of beta sheet side chain interactions. Science (1995) 1.88

Redesigning the hydrophobic core of a four-helix-bundle protein. Protein Sci (1994) 1.79

What makes a protein a protein? Hydrophobic core designs that specify stability and structural properties. Protein Sci (1996) 1.76

Recurrent miscarriage. BMJ (1991) 1.72

HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Transplantation (1994) 1.71

A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. Proc Natl Acad Sci U S A (2000) 1.70

An inverse correlation between loop length and stability in a four-helix-bundle protein. Fold Des (1997) 1.57

Characterization of skin-infiltrating lymphocytes in patients with psoriasis. J Invest Dermatol (1991) 1.55

Radioimmunoassay of myoglobin in human serum. Results in patients with acute myocardial infarction. J Clin Invest (1975) 1.55

Is maternal underweight really a risk factor for adverse pregnancy outcome? A population-based study in London. BJOG (2001) 1.53

Dissecting RNA-protein interactions: RNA-RNA recognition by Rop. Cell (1995) 1.53

Alpha-heavy chain disease, Mediterranean lymphoma, and immunoproliferative small intestinal disease: a review of clinicopathological features, pathogenesis, and differential diagnosis. Am J Gastroenterol (1999) 1.53

Why are secondary metabolites (natural products) biosynthesized? J Nat Prod (1990) 1.50

Glucose production by the human placenta in vivo. Placenta (1999) 1.42

Factor V Leiden and recurrent miscarriage-prospective outcome of untreated pregnancies. Hum Reprod (2002) 1.42

Novel metal-binding proteins by design. Nat Struct Biol (1995) 1.41

Marvin Jules Stone, MD, MACP: a conversation with the editor. Interview by William Clifford Roberts. Proc (Bayl Univ Med Cent) (2001) 1.41

Brief report: donor-derived long-term multilineage hematopoiesis in a liver-transplant recipient. N Engl J Med (1993) 1.40

Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects. Clin Sci (Lond) (2002) 1.38

Serum myoglobin level as diagnostic test in patients with acute myocardial infarction. Br Heart J (1977) 1.32

Dispensable pieces of an aminoacyl tRNA synthetase which activate the catalytic site. Cell (1984) 1.28

Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod (1997) 1.28

Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas. Ultrasound Obstet Gynecol (2009) 1.27

Obstetric risks of pregnancy in women less than 18 years old. Obstet Gynecol (2000) 1.27

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess (2006) 1.27

Dramatic structural and thermodynamic consequences of repacking a protein's hydrophobic core. Structure (2000) 1.27

A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Blood (1993) 1.27

Association of bacterial vaginosis with a history of second trimester miscarriage. Hum Reprod (1996) 1.26

The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complex. J Mol Biol (1998) 1.24

Amino-acid substitutions in a surface turn modulate protein stability. Nat Struct Biol (1996) 1.22

Gonadotrophin-releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata. Obstet Gynecol (2006) 1.20

Reproductive outcomes in women with congenital uterine anomalies detected by three-dimensional ultrasound screening. Obstet Gynecol (2001) 1.19

Magnetic resonance guided focused ultrasound surgery of uterine fibroids--the tissue effects of GnRH agonist pre-treatment. Eur J Radiol (2006) 1.18

Binding properties of a Waldenström macroglobulin antibody. J Biol Chem (1968) 1.18

A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Hum Reprod (2004) 1.16

Transmuting alpha helices and beta sheets. Fold Des (1997) 1.15

Overexpression of myoglobin and assignment of its amide, C alpha and C beta resonances. J Biomol NMR (1995) 1.15

Studies on monoclonal antibodies. I. The specificity and binding properties of a Waldenström macroglobulin with anti- G activity. J Lab Clin Med (1973) 1.14

Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease. Cancer Res (1993) 1.13

Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization. Fertil Steril (2000) 1.13

Sidechain interactions in parallel beta sheets: the energetics of cross-strand pairings. Structure (1999) 1.13

Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod (1999) 1.10

Surface point mutations that significantly alter the structure and stability of a protein's denatured state. Protein Sci (1996) 1.09

Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer. Clin Cancer Res (2001) 1.07

Relationships between protein structure and dynamics from a database of NMR-derived backbone order parameters. J Mol Biol (2000) 1.06

The evolutionary role of secondary metabolites--a review. Gene (1992) 1.06

Effect of tumour necrosis factor-alpha and interleukin 1beta on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro. Br J Pharmacol (2003) 1.06

Effect of alteration of the acetic acid synthesis pathway on the fermentation pattern of escherichia coli. Biotechnol Bioeng (1991) 1.05

NMR solution structure and receptor peptide binding of the CC chemokine eotaxin-2. Biochemistry (2000) 1.05

Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod (2001) 1.05

Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genes. Clin Exp Immunol (2001) 1.05

Recurrent miscarriage--an aspirin a day? Hum Reprod (2000) 1.04

Understanding the sequence determinants of conformational switching using protein design. Protein Sci (2000) 1.04

Polypeptide sequences essential for RNA recognition by an enzyme. Science (1987) 1.02

The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis. Am J Med (1975) 1.02

NMR mapping of the recombinant mouse major urinary protein I binding site occupied by the pheromone 2-sec-butyl-4,5-dihydrothiazole. Biochemistry (1999) 1.01

Reengineering granulocyte colony-stimulating factor for enhanced stability. J Biol Chem (2001) 1.01

Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome. Placenta (2005) 1.01

Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia. Haemophilia (2009) 1.01

Aromatic rescue of glycine in beta sheets. Fold Des (1998) 0.99

Characterization of metal binding by a designed protein: single ligand substitutions at a tetrahedral Cys2His2 site. Biochemistry (1995) 0.99

Large cell lymphomas of the stomach: improved prognosis with complete resection of all intrinsic gastrointestinal disease. J Clin Oncol (1983) 0.99

Mutational mapping of functional residues in tissue factor: identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain. Biochemistry (1994) 0.99

Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod (2002) 0.98

Characterization of binding between the chemokine eotaxin and peptides derived from the chemokine receptor CCR3. J Biol Chem (2000) 0.98

Active monomeric and dimeric forms of Pseudomonas putida glyoxalase I: evidence for 3D domain swapping. Biochemistry (1998) 0.97

Myoglobinemia is an early and quantitative index of acute myocardial infarction. Angiology (1978) 0.97

Comparison of five commercial serological tests for the detection of anti-Chlamydia trachomatis antibodies. Eur J Clin Microbiol Infect Dis (2010) 0.97

Peripheral neuropathies in Waldenström's macroglobulinaemia. J Neurol Neurosurg Psychiatry (2006) 0.97

Creatine kinase BB isoenzyme levels by radioimmunoassay in patients with neurological disease. Ann Neurol (1978) 0.97

Hepatic failure as the presenting manifestation of malignant lymphoma. Clin Lymphoma (2001) 0.96

The specificity of a monoclonal macroglobulin (gamma M) antibody: reactivity with primate gamma G immunoglobulins. J Immunol (1969) 0.96

Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol (1999) 0.96

Comparison of IV salbutamol with IV aminophylline in the treatment of severe, acute asthma in childhood. Arch Dis Child (1979) 0.96

Genetic thrombophilic mutations among couples with recurrent miscarriage. Hum Reprod (2006) 0.95

Inhibition of spontaneous receptor phosphorylation by residues in a putative alpha-helix in the KIT intracellular juxtamembrane region. J Biol Chem (1999) 0.95

Detection of myoglobin by radioimmmunoassay in human sera: its usefulness and limitations as an emergency room screening test for acute myocardial infarction. Am Heart J (1978) 0.95

A further look at infection at the time of therapeutic abortion. Eur J Obstet Gynecol Reprod Biol (1990) 0.95

Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod (2000) 0.95

Reproducibility of three-dimensional ultrasound diagnosis of congenital uterine anomalies. Ultrasound Obstet Gynecol (2003) 0.95

A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod (2003) 0.95

High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod (1995) 0.94

A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity. J Biol Chem (1998) 0.94

Immunochemical and structural similarities in toxin A and toxin B of Clostridium difficile shown by binding to monoclonal antibodies. Toxicon (1988) 0.93